Literature DB >> 1511390

Staging of cancer of the colon and rectum.

O H Beahrs1.   

Abstract

Entities:  

Mesh：

Year:  1992        PMID： 1511390     DOI： 10.1002/1097-0142(19920901)70:3+<1393::aid-cncr2820701530>3.0.co;2-p

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  10 in total

1.  Effect of left colonic artery preservation on anastomotic leakage in laparoscopic anterior resection for middle and low rectal cancer.

Authors:  Takao Hinoi; Masazumi Okajima; Manabu Shimomura; Hiroyuki Egi; Hideki Ohdan; Fumio Konishi; Kenichi Sugihara; Masahiko Watanabe
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

2.  Diagnostic and prognostic value of metastasis inducer S100A4 transcripts in plasma of colon, rectal, and gastric cancer patients.

Authors:  Ulrike Stein; Susen Burock; Pia Herrmann; Ina Wendler; Markus Niederstrasser; Klaus-Dieter Wernecke; Peter M Schlag
Journal:  J Mol Diagn       Date:  2011-03       Impact factor: 5.568

3.  The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis.

Authors:  Zhengyan Chang; Runzhi Huang; Wanting Fu; Jiehan Li; Guo Ji; Jinglei Huang; Weijun Shi; Huabin Yin; Weifeng Wang; Tong Meng; Zongqiang Huang; Qing Wei; Huanlong Qin
Journal:  Front Cell Dev Biol       Date:  2020-08-04

4.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

5.  An immunohistochemical study of EGFR expression in colorectal cancer and its correlation with lymph nodes status and tumor grade.

Authors:  Mojgan Mokhtari; Mina Memar Ardestani; Mohammad Movahedipour
Journal:  J Res Med Sci       Date:  2012-08       Impact factor: 1.852

6.  Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer.

Authors:  S Ganesh; C F Sier; M M Heerding; J H van Krieken; G Griffioen; K Welvaart; C J van de Velde; J H Verheijen; C B Lamers; H W Verspaget
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

7.  HER 2/neu protein expression in colorectal cancer.

Authors:  B Schuell; T Gruenberger; W Scheithauer; Ch Zielinski; F Wrba
Journal:  BMC Cancer       Date:  2006-05-08       Impact factor: 4.430

8.  STK31 as novel biomarker of metastatic potential and tumorigenicity of colorectal cancer.

Authors:  Lan Zhong; Jing Liu; Yedong Hu; Wei Wang; Fei Xu; Wen Xu; Junyi Han; Ewelina Biskup
Journal:  Oncotarget       Date:  2017-04-11

9.  Operative safety and oncologic outcomes in rectal cancer based on the level of inferior mesenteric artery ligation: a stratified analysis of a large Korean cohort.

Authors:  Mohammed A AlSuhaimi; Seung Yoon Yang; Jae Hyun Kang; Jamal F AlSabilah; Hyuk Hur; Nam Kyu Kim
Journal:  Ann Surg Treat Res       Date:  2019-11-01       Impact factor: 1.859

10.  Superoxide dismutases in relation to the overall survival of colorectal cancer patients.

Authors:  A M Janssen; C B Bosman; C F Sier; G Griffioen; F J Kubben; C B Lamers; J H van Krieken; C J van de Velde; H W Verspaget
Journal:  Br J Cancer       Date:  1998-10       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.